Share

Crossing Borders: The Impact of the Travel Ban

Al_Nofal_Alaa_MUG_RGB [UPDATE: Since this story went to print, the Trump administration has issued a new travel ban that places restrictions on immigrants from Chad, Iran, Libya, North Korea, Somalia, Syria, Venezuela, and Yemen. Therefore, the Supreme Court postponed oral arguments in the travel ban case that were scheduled for October.] While the ACA repeal effort is ongoing...
Share

Hormone Scientists Head for the Mountains

Lange, Carol 2016 Hormone researchers from around the world will be descending on Snowmass Village, Colo., in June for the FASEB Science Research Conference focused on steroid hormone receptors. Conference co-organizer Carol Lange, PhD, tells us why endocrine scientists dedicated to this field should attend. The Federation of American Societies for Experimental Biology (FASEB) is hosting its Science...
Share

Lab Partners

katzenellenbogens John and Benita Katzenellenbogen, PhDs, are partners in both life and in the lab. Endocrine News asked this award-winning couple about their careers, their research, and, of course, how they met. For the first time in history, the Endocrine Society’s 2016 Fred Conrad Koch Lifetime Achievement Award was awarded to a married couple, Benita and...
Share

Lab Notes Q&A: A Peculiar Trait

Endocrine News talks to Márta Korbonits, MD, PhD, at the Queen Mary University of London about her research in seeking the mutations behind a familial adenoma. About one in every thousand individuals will develop a pituitary adenoma, a noncancerous but disruptive tumor on the pituitary gland that can induce a variety negative side effects. But,...
Share

Q&A: When Bad Fat Goes Good

Endocrine News talks to Philip Kern, MD, at the University of Kentucky about the phenomenon of “beige” fat and what it means for the future of obesity research. Heat usually melts fat — like butter in a sunbeam — but in mammals, cold may actually burn off adipose tissue. For “brown fat,” this is no...
Share

Lab Notes Q&A: Genetic Mutations and Breast Cancer

Endocrine News talks to Sarat Chandarlapaty, MD, PhD, about his research on genetic mutations and breast cancer, his methods, and what impact it might have on the field of endocrinology. Estrogen-disrupting therapies such as fulvestrant and tamoxifen have achieved great success in treating breast cancer. Such drugs, which block the estrogen receptor and inhibit the...